Export 155 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
H. Kaur, Golovko, S., Golovko, M. Y., Singh, S., Darland, D. C., and Combs, C. K., Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 76, no. 3, pp. 1083-1102, 2020.
M. J. Katz, Wang, C., Derby, C. A., Lipton, R. B., Zimmerman, M. E., Sliwinski, M. J., and Rabin, L. A., Subjective Cognitive Decline Prediction of Mortality: Results from the Einstein Aging Study., J Alzheimers Dis, vol. 66, no. 1, pp. 239-248, 2018.
K. Katisko, Kokkonen, N., Krüger, J., Hartikainen, P., Koivisto, A. M., Helisalmi, S., Korhonen, V. E., Kokki, M., Tuusa, J., Herukka, S. - K., Solje, E., Haapasalo, A., Tasanen, K., and Remes, A. M., The Association Between Frontotemporal Lobar Degeneration and Bullous Pemphigoid., J Alzheimers Dis, vol. 66, no. 2, pp. 743-750, 2018.
K. Katisko, Haapasalo, A., Koivisto, A., Krüger, J., Hartikainen, P., Korhonen, V., Helisalmi, S., Herukka, S. - K., Remes, A. M., and Solje, E., Low Prevalence of Cancer in Patients with Frontotemporal Lobar Degeneration., J Alzheimers Dis, vol. 62, no. 2, pp. 789-794, 2018.
Á. Kasza, Hunya, Á., Frank, Z., Fülöp, F., Török, Z., Balogh, G., Sántha, M., Bálind, Á., Bernáth, S., Blundell, K. L. I. M., Prodromou, C., Horváth, I., Zeiler, H. - J., Hooper, P. L., Vigh, L., and Penke, B., Dihydropyridine Derivatives Modulate Heat Shock Responses and have a Neuroprotective Effect in a Transgenic Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 2, pp. 557-71, 2016.
N. Kasahata, Sato, T., Onishi, I., Kitagawa, M., Uchihara, T., and Hirokawa, K., Three-Repeat Tau with Grain-Like Structures and Distribution in an 83-Year-Old Man., J Alzheimers Dis, vol. 58, no. 3, pp. 681-685, 2017.
R. Karki, Kodamullil, A. Tom, and Hofmann-Apitius, M., Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs., J Alzheimers Dis, vol. 60, no. 2, pp. 721-731, 2017.
T. K. Karikari, Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance., J Alzheimers Dis, vol. 90, no. 3, pp. 967-974, 2022.
A. Karch, Llorens, F., Schmitz, M., Arora, A. Singh, Zafar, S., Lange, P., Schmidt, C., and Zerr, I., Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia., J Alzheimers Dis, vol. 54, no. 4, pp. 1385-1393, 2016.
I. Karakis, Pase, M. P., Beiser, A., Booth, S. L., Jacques, P. F., Rogers, G., DeCarli, C., Vasan, R. S., Wang, T. J., Himali, J. J., Annweiler, C., and Seshadri, S., Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study., J Alzheimers Dis, vol. 51, no. 2, pp. 451-61, 2016.
K. Kara, Mahabadi, A. Abbas, Weimar, C., Winkler, A., Neumann, T., Kälsch, H., Dragano, N., Moebus, S., Erbel, R., Jöckel, K. - H., and Jokisch, M., N-Terminal Pro-B Type Natriuretic Peptide is Associated with Mild Cognitive Impairment in the General Population., J Alzheimers Dis, vol. 55, no. 1, pp. 359-369, 2017.
A. Kapoor, Bartha, R., Black, S. E., Borrie, M., Freedman, M., Gao, F., Herrmann, N., Mandzia, J., Ozzoude, M., Ramirez, J., Scott, C. J. M., Symons, S., Fischer, C. E., Frank, A., Seitz, D., Wolf, M. Uri, Verhoeff, N. Paul L. G., Naglie, G., Reichman, W., Masellis, M., Mitchell, S. B., Tang-Wai, D. F., Tartaglia, M. Carmela, Kumar, S., Pollock, B. G., Rajji, T. K., Finger, E., Pasternak, S. H., and Swartz, R. H., Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years., J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
D. Kapogiannis and Mattson, M. P., Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease., Lancet Neurol, vol. 10, no. 2, pp. 187-98, 2011.
A. Kapasi, Yu, L., Stewart, C., Schneider, J. A., Bennett, D. A., and Boyle, P. A., Association of Amyloid-β Pathology with Decision Making and Scam Susceptibility., J Alzheimers Dis, vol. 83, no. 2, pp. 879-887, 2021.
M. Kapadia, M Mian, F., Michalski, B., Azam, A. B., Ma, D., Salwierz, P., Christopher, A., Rosa, E., Zovkic, I. B., Forsythe, P., Fahnestock, M., and Sakic, B., Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice., J Alzheimers Dis, vol. 63, no. 3, pp. 1191-1205, 2018.
K. Kantarci, Lowe, V. J., Lesnick, T. G., Tosakulwong, N., Bailey, K. R., Fields, J. A., Shuster, L. T., Zuk, S. M., Senjem, M. L., Mielke, M. M., Gleason, C., Jack, C. R., Rocca, W. A., and Miller, V. M., Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition., J Alzheimers Dis, vol. 53, no. 2, pp. 547-56, 2016.
S. Kang, Jeong, H., Baek, J. - H., Lee, S. - J., Han, S. - H., Cho, H. Jin, Kim, H., Hong, H. Seok, Kim, Y. Ho, Yi, E. C., Seo, S. Won, Na, D. L., Hwang, D., and Mook-Jung, I., PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 4, pp. 1563-76, 2016.
J. Myeong Kang, Yeon, B. Kil, Cho, S. - J., and Suh, Y. - H., Stem Cell Therapy for Alzheimer's Disease: A Review of Recent Clinical Trials., J Alzheimers Dis, vol. 54, no. 3, pp. 879-889, 2016.
R. Kandimalla and P Reddy, H., Therapeutics of Neurotransmitters in Alzheimer's Disease., J Alzheimers Dis, vol. 57, no. 4, pp. 1049-1069, 2017.
N. Kandiah, Wang, V., Lin, X., Nyu, M. Mei, Lim, L., Ng, A., Hameed, S., and Wee, H. Lin, Cost Related to Dementia in the Young and the Impact of Etiological Subtype on Cost., J Alzheimers Dis, vol. 49, no. 2, pp. 277-85, 2016.
N. Kandiah, Chander, R. Jude, Lin, X., Ng, A., Poh, Y. Yeong, Cheong, C. Yee, Cenina, A. Rae, and Assam, P. Nkouibert, Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score., J Alzheimers Dis, vol. 49, no. 4, pp. 1169-77, 2016.
A. Kaminari, Tsilibary, E. C., and Tzinia, A., A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus., J Alzheimers Dis, vol. 64, no. 1, pp. 1-16, 2018.
Y. Kamikubo, Takasugi, N., Niisato, K., Hashimoto, Y., and Sakurai, T., Consecutive Analysis of BACE1 Function on Developing and Developed Neuronal Cells., J Alzheimers Dis, vol. 56, no. 2, pp. 641-653, 2017.
D. M. Kamara, Gangishetti, U., Gearing, M., Willis-Parker, M., Zhao, L., Hu, W. T., and Walker, L. C., Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease., J Alzheimers Dis, vol. 62, no. 4, pp. 1815-1826, 2018.
E. - L. Kallio, Öhman, H., Kautiainen, H., Hietanen, M., and Pitkälä, K., Cognitive Training Interventions for Patients with Alzheimer's Disease: A Systematic Review., J Alzheimers Dis, vol. 56, no. 4, pp. 1349-1372, 2017.